Serum Procalcitonin in Patients With Combined Lung Cancer and Idiopathic Pulmonary Fibrosis (LC-IPF)

Background Procalcitonin (PCT) is a potential biomarker for sepsis and acts as a guide to antibiotic administration. Previous studies showed that lung cancer (LC) may increase serum PCT levels. However, no studies addressed serum PCT in patients with combined LC and idiopathic pulmonary fibrosis (IP...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamed, Sherif, Abdelhaffez, Azza, Abd El-Aziz, Nashwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458704/
https://www.ncbi.nlm.nih.gov/pubmed/32879828
http://dx.doi.org/10.7759/cureus.9507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458704/
https://www.ncbi.nlm.nih.gov/pubmed/32879828
http://dx.doi.org/10.7759/cureus.9507

Ejemplares similares